Bicara Therapeutics Inc (BCAX)

05:35 AM

Is Bicara Therapeutics Inc. stock trading at a premium valuationWeekly Trade Review & Precise Trade Entry Recommendations - ulpravda.ru

05:35 AM

05:06 AM

BTIG Research Begins Coverage on Bicara Therapeutics (NASDAQ:BCAX) - Defense World

05:06 AM

Jan 09, 2026

Published on: 2026-01-09 02:43:58 - ulpravda.ru

Jan 09, 2026

Jan 09, 2026

Is Bicara Therapeutics Inc. stock a defensive play in 2025July 2025 Breakouts & Safe Entry Trade Signal Reports - ulpravda.ru

Jan 09, 2026

Jan 08, 2026

BTIG Initiates Coverage of Bicara Therapeutics (BCAX) with Buy Recommendation - Nasdaq

Jan 08, 2026

Jan 08, 2026

What hedge fund activity signals for Bicara Therapeutics Inc. stockQuarterly Profit Summary & AI Based Trade Execution Alerts - ulpravda.ru

Jan 08, 2026

Jan 08, 2026

Bicara Therapeutics initiated with a Buy at BTIG - TipRanks

Jan 08, 2026

Jan 08, 2026

BTIG initiates coverage on Bicara Therapeutics stock with Buy rating By Investing.com - Investing.com UK

Jan 08, 2026

Jan 08, 2026

BTIG initiates coverage on Bicara Therapeutics stock with Buy rating - Investing.com

Jan 08, 2026

Jan 07, 2026

Can Bicara Therapeutics Inc. stock rebound after recent weaknessEarnings Date Calendar & Free Grow Wealth With Picks - ulpravda.ru

Jan 07, 2026

Jan 06, 2026

Bicara Therapeutics: How InvestingPro’s overvaluation call led to 39% decline By Investing.com - Investing.com South Africa

Jan 06, 2026

Jan 06, 2026

Will Bicara Therapeutics Inc. stock continue dividend increases2026 world cup usa national team group stage playmakers pressing system winner prediction preview - Улправда

Jan 06, 2026

Jan 05, 2026

Bicara Therapeutics Inc. (NASDAQ:BCAX) Receives Consensus Rating of “Hold” from Analysts - Defense World

Jan 05, 2026

Jan 05, 2026

Bicara Therapeutics Inc. (NASDAQ:BCAX) Receives Consensus Rating of "Hold" from Analysts - MarketBeat

Jan 05, 2026

Jan 03, 2026

What Drawdown Risk Means for Long Term Holders of Clean Science and Technology LimitedStock Buyback Announcements & Zero-Cost Stock Research by Professionals - earlytimes.in

Jan 03, 2026

Jan 02, 2026

Bicara Therapeutics (NASDAQ:BCAX) Trading 3.9% Higher – Here’s Why - Defense World

Jan 02, 2026

Dec 31, 2025

Bicara Therapeutics (NASDAQ:BCAX) Stock Price Up 3.9%Still a Buy? - MarketBeat

Dec 31, 2025

Dec 29, 2025

Straddle Buy Call Buy Put at same strikeEarnings Call Summaries & Exceptional Return Growth - bollywoodhelpline.com

Dec 29, 2025

Dec 24, 2025

Hyep Ivan, Bicara Therapeutics CFO, sells $168k in BCAX stock - Investing.com India

Dec 24, 2025

Dec 24, 2025

Hyep Ivan, Bicara Therapeutics CFO, sells $168k in BCAX stock By Investing.com - Investing.com Nigeria

Dec 24, 2025

Dec 23, 2025

Bicara Therapeutics (BCAX) Valuation After Dual Biotechnology Index Additions - Yahoo Finance

Dec 23, 2025

Dec 23, 2025

How Bicara's Dual Biotech Index Additions Will Impact Bicara Therapeutics (BCAX) Investors - simplywall.st

Dec 23, 2025

Dec 22, 2025

The Bull Case For Bicara Therapeutics (BCAX) Could Change Following Dual Inclusion In Major Biotech Indices - Yahoo Finance

Dec 22, 2025

Dec 22, 2025

Bicara Therapeutics Inc.(NasdaqGM: BCAX) added to NASDAQ Biotechnology Index - marketscreener.com

Dec 22, 2025

Dec 21, 2025

Bicara Therapeutics Inc.(NasdaqGM:BCAX) added to S&P Biotechnology Select Industry Index - marketscreener.com

Dec 21, 2025

Dec 20, 2025

Bicara Therapeutics (NASDAQ:BCAX) Raised to Hold at Mizuho - Defense World

Dec 20, 2025

Dec 20, 2025

Will Bicara Therapeutics Inc. stock deliver better than expected guidanceEarnings Recap Report & Weekly High Potential Alerts - Улправда

Dec 20, 2025

Dec 19, 2025

Published on: 2025-12-19 16:38:22 - Bölüm Sonu Canavarı

Dec 19, 2025

Dec 19, 2025

Bicara Therapeutics (NASDAQ:BCAX) Raised to "Hold" at Mizuho - MarketBeat

Dec 19, 2025

Dec 18, 2025

What makes Bicara Therapeutics Inc. stock attractive to growth fundsFed Meeting & Technical Pattern Recognition Alerts - Улправда

Dec 18, 2025

Dec 18, 2025

Can Bicara Therapeutics Inc. stock reach $100 price target2025 Earnings Impact & Long-Term Investment Growth Plans - ulpravda.ru

Dec 18, 2025

Dec 18, 2025

Mizuho Initiates Coverage of Bicara Therapeutics (BCAX) with Neutral Recommendation - Nasdaq

Dec 18, 2025

Dec 18, 2025

Mizuho Initiates Bicara Therapeutics at Neutral With $18 Price Target - marketscreener.com

Dec 18, 2025

Dec 18, 2025

Bicara Therapeutics (BCAX) Receives Neutral Rating from Mizuho | - GuruFocus

Dec 18, 2025

Dec 17, 2025

Mizuho initiates Bicara Therapeutics stock coverage with Neutral rating By Investing.com - Investing.com Canada

Dec 17, 2025

Dec 17, 2025

Mizuho initiates Bicara Therapeutics stock coverage with Neutral rating - Investing.com

Dec 17, 2025

Dec 17, 2025

Bicara Therapeutics initiated with a Neutral at Mizuho - TipRanks

Dec 17, 2025

Dec 16, 2025

Bicara Therapeutics (NASDAQ:BCAX) COO Ryan Cohlhepp Sells 12,500 Shares - MarketBeat

Dec 16, 2025

Dec 15, 2025

Bicara Therapeutics to Present at the J.P. Morgan 2026 Annual Healthcare Conference on Monday, January 12 - The Manila Times

Dec 15, 2025

Dec 11, 2025

Bicara Therapeutics Inc. (NASDAQ:BCAX) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Dec 11, 2025